Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-04-13 @ 9:33 PM
Study NCT ID:
NCT03535961
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2017-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
CH-BC-055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None